NextPlat (NXPL) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
1 Jun, 2026Business overview and strategy
Operates globally in healthcare and technology, offering pharmacy, data management, and e-commerce solutions across 150+ countries.
Focuses on high-growth sectors: healthcare, consumer wellness, and satellite connectivity.
Provides proprietary AI-powered software for healthcare analytics, prescription management, and global e-commerce enablement.
Expanding e-commerce and healthcare services domestically and internationally, including Asia and the Americas.
Turnaround initiatives and operational improvements
Implemented new leadership, efficiency programs, and business development teams targeting high-margin healthcare contracts.
Reduced annualized overhead by over $2 million and staff by more than 25%.
Achieved record consolidated gross margin of 35% in Q1 2026, with high-margin prescription volumes exceeding 7,500 per month.
Expanded healthcare revenue from Florida to all 50 states and launched new online fulfillment offerings.
Financial performance and outlook
Reported $54.3 million in 2025 revenue and $9.9 million in Q1 2026, with $11 million in cash as of March 31, 2026.
Consolidated gross margin reached 35% in Q1 2026; operating expenses declined 9% sequentially.
Net loss of $1.1 million in Q1 2026, improved from $11.7 million loss in 2025.
Clean balance sheet with no long-term debt and high insider ownership (46%).
Latest events from NextPlat
- All proposals passed, including director elections and auditor ratification.NXPL
AGM 202624 Jun 2026 - Registering 2,097,011 shares for resale, with no proceeds to the company and significant dilution risk.NXPL
Registration filing3 Jun 2026 - Record 35% gross margin and reduced losses highlight progress in turnaround and growth.NXPL
Q1 202620 May 2026 - Turnaround drives margin growth, nationwide expansion, and global e-commerce momentum.NXPL
Corporate presentation7 May 2026 - Registering 2.65M shares for resale, with no proceeds to the company and ongoing net losses.NXPL
Registration filing6 May 2026 - Shareholders will vote virtually on director elections, auditor ratification, and executive pay.NXPL
Proxy filing30 Apr 2026 - Virtual annual meeting to vote on board, auditor, and executive pay set for June 24, 2026.NXPL
Proxy filing30 Apr 2026 - Turnaround delivers cost cuts, margin gains, and nationwide healthcare expansion for 2026 growth.NXPL
Corporate presentation7 Apr 2026 - Cost reductions and a margin-focused strategy position the business for profitability in 2026.NXPL
Q4 20251 Apr 2026